Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-17
2007-07-17
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000, C530S325000, C530S326000, C530S327000, C514S012200, C514S013800, C514S014800, C514S015800, C436S089000
Reexamination Certificate
active
10249607
ABSTRACT:
The invention comprises a preparation of X-S-Cys-X, moiety, BRAUNMYCIN Î>>, where X maybe naturally linked peptide or glycan residues essential for iron-reductase activity, as well as methods of obtaining preparation from an iron-nitriloacetic acid iron binding jaw, BRAUNMYCIN8567, a component of a batch affinity column; and any interpretation derived from this outcome, like, but not limited to, detection of resistance, to iron-containing antibiotics, in DNA synthesizing cells.
REFERENCES:
patent: 7109480 (2006-09-01), Vestal et al.
patent: 7166441 (2007-01-01), Nadler et al.
patent: 2004/0076981 (2004-04-01), Yoder et al.
Lukton David
Olisa, III Nzedegwu Robert
LandOfFree
Purified Cys moiety for iron reductase, and method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purified Cys moiety for iron reductase, and method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purified Cys moiety for iron reductase, and method for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3781054